SUBSTITUTED TRICYCLIC BENZIMIDAZOLES AS KINASE INHIBITORS
申请人:SELVITA S.A.
公开号:EP2917217B1
公开(公告)日:2017-03-08
US20140275030A1
申请人:——
公开号:US20140275030A1
公开(公告)日:2014-09-18
TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS
申请人:Incyte Corporation
公开号:US20170210754A1
公开(公告)日:2017-07-27
The present invention relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.